Compare $DCOY vs $ERNA | Chartloom

Compare

$DCOY vs $ERNA

Decoy Therapeutics Inc · Ernexa Therapeutics Inc

DCOY

Decoy Therapeutics Inc

ERNA

Ernexa Therapeutics Inc

Compare $DCOY vs $ERNA

Comparing Decoy Therapeutics Inc and Ernexa Therapeutics Inc

DCOYDecoy Therapeutics Inc

ERNAErnexa Therapeutics Inc

DCOYDecoy Therapeutics Inc

Market cap

$779K

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-97.0%

FCF yield

-1073.9%

ERNAErnexa Therapeutics Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-91.7%

52W performance

-93.0%

FCF yield

-316.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DCOY

ERNA

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

ERNA

Ernexa Therapeutics Inc

Market Cap

DCOY$779K

ERNA$3M

Enterprise Value

DCOY$-8M

ERNA$-2M

Price

DCOY$1.47

ERNA$2.40

P/E Ratio

DCOYN/A

ERNAN/A

P/S Ratio

DCOY3.42x

ERNA8.30x

EV/Sales

DCOY-33.00x

ERNA0.09x

EV/EBITDA

DCOY0.00x

ERNA0.00x

P/B Ratio

DCOY0.75x

ERNA1.51x

P/FCF Ratio

DCOYN/A

ERNAN/A

EV/FCF

DCOY0.90x

ERNA0.22x

PEG Ratio

DCOYN/A

ERNAN/A

Forward P/E (NTM)

DCOYN/A

ERNAN/A

Forward P/S (NTM)

DCOYN/A

ERNAN/A

Revenue (TTM)

DCOY$228K

ERNA$0

Revenue Growth (YoY)

DCOYN/A

ERNAN/A

Forward Rev Growth

DCOY0.0%

ERNA0.0%

Gross Margin (TTM)

DCOY48.6%

ERNA83.5%

Operating Margin (TTM)

DCOY0.0%

ERNA0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

ERNA0.0%

Net Margin (TTM)

DCOY-6348.7%

ERNA0.0%

FCF Margin (TTM)

DCOY-3676.1%

ERNAN/A

Net Income (TTM)

DCOY$-14M

ERNA$-3M

FCF (TTM)

DCOY$-8M

ERNA$-9M

EPS (TTM)

DCOY-$27.16

ERNA$0.00

ROE (TTM)

DCOY-31523.0%

ERNA-16940.0%

ROA (TTM)

DCOY-16715.0%

ERNA-22854.0%

ROIC (TTM)

DCOY-31523.0%

ERNA-15802.0%

Cash

DCOY$8M

ERNA$5M

Debt

DCOY$0

ERNA$250K

Net Cash/Debt

DCOY$8M

ERNA$5M

Current Ratio (TTM)

DCOY1.83x

ERNA2.01x

Quick Ratio (TTM)

DCOY1.77x

ERNA1.74x

Debt/Equity (TTM)

DCOY0.00x

ERNA0.08x

Debt/Assets (TTM)

DCOY0.0%

ERNA0.0%

Interest Coverage (TTM)

DCOYN/A

ERNAN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

ERNA0.00x

Beta

DCOY0.68

ERNA2.68

52W Performance

DCOY-97.0%

ERNA-93.0%

YTD Performance

DCOY-81.2%

ERNA-91.7%

% from 52W High

DCOY-97.4%

ERNA-96.6%

% from 52W Low

DCOY0.7%

ERNA13.2%

Asset Turnover (TTM)

DCOY0.03x

ERNA0.02x

FCF Yield (TTM)

DCOY-1073.9%

ERNA-316.2%

Earnings Yield (TTM)

DCOY-1854.7%

ERNA-97.9%

Dividend Yield (TTM)

DCOYN/A

ERNA0.4%

Rule of 40

DCOY-3,676.1

ERNA0.0

EV/GP/RG

DCOYN/A

ERNAN/A

Ticker research

View DCOY research View ERNA research

Metric	DCOY Decoy Therapeutics Inc	ERNA Ernexa Therapeutics Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$-2M
Price	$1.47	$2.40
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	8.30x
EV/Sales	-33.00x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	1.51x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	0.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	83.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	0.0%
Net Margin (TTM)	-6348.7%	0.0%
FCF Margin (TTM)	-3676.1%	N/A
Net Income (TTM)	$-14M	$-3M
FCF (TTM)	$-8M	$-9M
EPS (TTM)	-$27.16	$0.00
ROE (TTM)	-31523.0%	-16940.0%
ROA (TTM)	-16715.0%	-22854.0%
ROIC (TTM)	-31523.0%	-15802.0%
Financial Health
Cash	$8M	$5M
Debt	$0	$250K
Net Cash/Debt	$8M	$5M
Current Ratio (TTM)	1.83x	2.01x
Quick Ratio (TTM)	1.77x	1.74x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	2.68
52W Performance	-97.0%	-93.0%
YTD Performance	-81.2%	-91.7%
% from 52W High	-97.4%	-96.6%
% from 52W Low	0.7%	13.2%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.02x
FCF Yield (TTM)	-1073.9%	-316.2%
Earnings Yield (TTM)	-1854.7%	-97.9%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	-3,676.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View ERNA research

Valuation

P/S Ratio

DCOY

3.42x

ERNA

8.30x

EV/FCF

ERNA

0.22x

DCOY

0.90x

Growth & revenue

Forward Revenue Growth

DCOY

0.0%

ERNA

0.0%

Profitability & performance

Gross Margin

ERNA

83.5%

DCOY

48.6%

ROE

ERNA

-16940.0%

DCOY

-31523.0%

FCF Yield %

ERNA

-316.2%

DCOY

-1073.9%

52-Week Performance

ERNA

-93.0%

DCOY

-97.0%

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

ERNA

Ernexa Therapeutics Inc

Market Cap

DCOY$779K

ERNA$3M

Enterprise Value

DCOY$-8M

ERNA$-2M

Price

DCOY$1.47

ERNA$2.40

P/E Ratio

DCOYN/A

ERNAN/A

P/S Ratio

DCOY3.42x

ERNA8.30x

EV/Sales

DCOY-33.00x

ERNA0.09x

EV/EBITDA

DCOY0.00x

ERNA0.00x

P/B Ratio

DCOY0.75x

ERNA1.51x

P/FCF Ratio

DCOYN/A

ERNAN/A

EV/FCF

DCOY0.90x

ERNA0.22x

PEG Ratio

DCOYN/A

ERNAN/A

Forward P/E (NTM)

DCOYN/A

ERNAN/A

Forward P/S (NTM)

DCOYN/A

ERNAN/A

Revenue (TTM)

DCOY$228K

ERNA$0

Revenue Growth (YoY)

DCOYN/A

ERNAN/A

Forward Rev Growth

DCOY0.0%

ERNA0.0%

Gross Margin (TTM)

DCOY48.6%

ERNA83.5%

Operating Margin (TTM)

DCOY0.0%

ERNA0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

ERNA0.0%

Net Margin (TTM)

DCOY-6348.7%

ERNA0.0%

FCF Margin (TTM)

DCOY-3676.1%

ERNAN/A

Net Income (TTM)

DCOY$-14M

ERNA$-3M

FCF (TTM)

DCOY$-8M

ERNA$-9M

EPS (TTM)

DCOY-$27.16

ERNA$0.00

ROE (TTM)

DCOY-31523.0%

ERNA-16940.0%

ROA (TTM)

DCOY-16715.0%

ERNA-22854.0%

ROIC (TTM)

DCOY-31523.0%

ERNA-15802.0%

Cash

DCOY$8M

ERNA$5M

Debt

DCOY$0

ERNA$250K

Net Cash/Debt

DCOY$8M

ERNA$5M

Current Ratio (TTM)

DCOY1.83x

ERNA2.01x

Quick Ratio (TTM)

DCOY1.77x

ERNA1.74x

Debt/Equity (TTM)

DCOY0.00x

ERNA0.08x

Debt/Assets (TTM)

DCOY0.0%

ERNA0.0%

Interest Coverage (TTM)

DCOYN/A

ERNAN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

ERNA0.00x

Beta

DCOY0.68

ERNA2.68

52W Performance

DCOY-97.0%

ERNA-93.0%

YTD Performance

DCOY-81.2%

ERNA-91.7%

% from 52W High

DCOY-97.4%

ERNA-96.6%

% from 52W Low

DCOY0.7%

ERNA13.2%

Asset Turnover (TTM)

DCOY0.03x

ERNA0.02x

FCF Yield (TTM)

DCOY-1073.9%

ERNA-316.2%

Earnings Yield (TTM)

DCOY-1854.7%

ERNA-97.9%

Dividend Yield (TTM)

DCOYN/A

ERNA0.4%

Rule of 40

DCOY-3,676.1

ERNA0.0

EV/GP/RG

DCOYN/A

ERNAN/A

Ticker research

View DCOY research View ERNA research

Metric	DCOY Decoy Therapeutics Inc	ERNA Ernexa Therapeutics Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$-2M
Price	$1.47	$2.40
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	8.30x
EV/Sales	-33.00x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	1.51x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	0.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	83.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	0.0%
Net Margin (TTM)	-6348.7%	0.0%
FCF Margin (TTM)	-3676.1%	N/A
Net Income (TTM)	$-14M	$-3M
FCF (TTM)	$-8M	$-9M
EPS (TTM)	-$27.16	$0.00
ROE (TTM)	-31523.0%	-16940.0%
ROA (TTM)	-16715.0%	-22854.0%
ROIC (TTM)	-31523.0%	-15802.0%
Financial Health
Cash	$8M	$5M
Debt	$0	$250K
Net Cash/Debt	$8M	$5M
Current Ratio (TTM)	1.83x	2.01x
Quick Ratio (TTM)	1.77x	1.74x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	2.68
52W Performance	-97.0%	-93.0%
YTD Performance	-81.2%	-91.7%
% from 52W High	-97.4%	-96.6%
% from 52W Low	0.7%	13.2%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.02x
FCF Yield (TTM)	-1073.9%	-316.2%
Earnings Yield (TTM)	-1854.7%	-97.9%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	-3,676.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View ERNA research